ANDA 74616, held by Hospira. Inamrinone Lactate.
As of Nov 15, 2026, ANDA 74616 (Amrinone Lactate), held by Hospira, was first approved by FDA on Aug 3, 1998, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 3, 1998 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Amrinone LactateEQ 5MG BASE/ML ยท injectable;injection | Inamrinone Lactate | Discontinued |
| Sep 7, 2001 | Supplement 2Manufacturing | Approved | None posted |
| Jul 24, 2000 | Supplement 1Labeling | Approved | None posted |
| Aug 3, 1998 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
